Japanese Designated Marketing Authorization Holders (DMAHs) must use specific IT tools and systems to comply with regulatory requirements. These include electronic submission gateways like PMDA’s Gateway System for drug applications, pharmacovigilance databases for adverse event reporting, and compliance management software to ensure adherence to Good Manufacturing Practice (GMP) and other regulations.
